WO1999036560A3 - Viral vectors encoding neurofilament light proteins and their use - Google Patents
Viral vectors encoding neurofilament light proteins and their use Download PDFInfo
- Publication number
- WO1999036560A3 WO1999036560A3 PCT/CA1999/000008 CA9900008W WO9936560A3 WO 1999036560 A3 WO1999036560 A3 WO 1999036560A3 CA 9900008 W CA9900008 W CA 9900008W WO 9936560 A3 WO9936560 A3 WO 9936560A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- neurofilament light
- viral vectors
- vectors encoding
- light proteins
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU19565/99A AU1956599A (en) | 1998-01-13 | 1999-01-13 | Viral vectors encoding neurofilament light proteins and their use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2220839 | 1998-01-13 | ||
CA2,220,839 | 1998-01-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999036560A2 WO1999036560A2 (en) | 1999-07-22 |
WO1999036560A3 true WO1999036560A3 (en) | 1999-09-30 |
Family
ID=4161756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1999/000008 WO1999036560A2 (en) | 1998-01-13 | 1999-01-13 | Viral vectors encoding neurofilament light proteins and their use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1956599A (en) |
WO (1) | WO1999036560A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018317807A1 (en) * | 2017-08-16 | 2020-02-06 | Roxiant ApS | VTFT isoform of a BPIFB4 protein for use in neuronal diseases and injuries |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008026A1 (en) * | 1992-09-25 | 1994-04-14 | Rhone-Poulenc Rorer S.A. | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
-
1999
- 1999-01-13 WO PCT/CA1999/000008 patent/WO1999036560A2/en active Application Filing
- 1999-01-13 AU AU19565/99A patent/AU1956599A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008026A1 (en) * | 1992-09-25 | 1994-04-14 | Rhone-Poulenc Rorer S.A. | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
Non-Patent Citations (5)
Title |
---|
BETT ET AL: "DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309", VIRUS RESEARCH, vol. 39, no. 1, 1995, pages 75 - 82, XP002106222 * |
JACOBS ET AL: "Recovery of Neurofilament Expression Selectively in Regenerating Reticulospinal Neurons", JOURNAL OF NEUROSCIENCE, vol. 17, no. 13, 1 July 1997 (1997-07-01), pages 5206 - 5220, XP002106229 * |
KARPATI ET AL: "The principles of gene therapy for the nervous system", TRENDS IN NEUROSCIENCE, vol. 19, 1996, pages 49 - 54, XP002106220 * |
MEIER J (REPRINT) ET AL: "In vivo alleviation of neurofilament swellings by viral mediated gene transfer.", MOLECULAR BIOLOGY OF THE CELL, (DEC 1996) VOL. 7, SUPP. [S], PP. 1263-1263A, XP002106218 * |
ZHU ET AL: "Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments", EXPERIMENTAL NEUROLOGY, vol. 148, 1997, pages 299 - 316, XP002106228 * |
Also Published As
Publication number | Publication date |
---|---|
AU1956599A (en) | 1999-08-02 |
WO1999036560A2 (en) | 1999-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002069900A3 (en) | Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors | |
WO2000054813A3 (en) | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye | |
WO2002024234A3 (en) | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye | |
WO1998021343A8 (en) | Genes encoding telomerase proteins | |
WO2000053776A3 (en) | Human kallikrein-like genes | |
AU2002303719A1 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
WO2003016551A3 (en) | Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof | |
WO2002010388A3 (en) | C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF | |
AU2002214542A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
WO1999036558A3 (en) | Viral vectors encoding neurofilament heavy proteins and their use | |
WO1999036560A3 (en) | Viral vectors encoding neurofilament light proteins and their use | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
AU2002258630A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2001288363A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
WO2002079222A3 (en) | Fusion proteins for specific treatment of cancer and auto-immune diseases | |
WO2001000662A3 (en) | The use of human fgh-8 polypeptides as neurotrophic agents | |
AU2002229060A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1383871A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2002245208A1 (en) | Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof | |
AU2002324475A1 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
AU2002257075A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002303137A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
WO2003099863A3 (en) | Resistin binding proteins, their preparation and use | |
AU2001253804A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |